Published in Virchows Arch A Pathol Anat Histol on May 14, 1979
Hedgehog signaling is required for effective regeneration of exocrine pancreas. Gastroenterology (2008) 2.71
IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer. Cancer Res (2015) 1.97
Myofibroblast proliferation, fibrosis, and defective pancreatic repair induced by cyclosporin in rats. Gut (1999) 1.66
Repetitive self-limited acute pancreatitis induces pancreatic fibrogenesis in the mouse. Dig Dis Sci (2000) 1.55
Oxygen free radicals in acute pancreatitis of the rat. Gut (1990) 1.42
Review of experimental animal models of acute pancreatitis. HPB (Oxford) (2006) 1.24
Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo. J Clin Invest (2007) 1.24
Hippo signaling regulates pancreas development through inactivation of Yap. Mol Cell Biol (2012) 1.21
Human pancreatic exocrine response to nutrients in health and disease. Gut (2005) 1.16
Hyperlipaemia intensifies the course of acute oedematous and acute necrotising pancreatitis in the rat. Gut (1996) 1.09
Increased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair. Gut (1997) 1.07
Protective effects of exogenous secretin on ceruletide-induced acute pancreatitis in the rat. J Clin Invest (1983) 1.01
Acinar cell apoptosis and the origin of tubular complexes in caerulein-induced pancreatitis. Int J Exp Pathol (1999) 0.99
Enhanced expression of TGF-betas and their receptors in human acute pancreatitis. Ann Surg (1998) 0.97
Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases. Curr Top Med Chem (2007) 0.95
Pancreatic growth and cell turnover in the rat fed raw soya flour. Am J Pathol (1982) 0.91
Combined treatment with C1 esterase inhibitor and antithrombin III improves survival in severe acute experimental pancreatitis. Gut (1997) 0.89
Protection from pancreatitis by the zymogen granule membrane protein integral membrane-associated protein-1. J Biol Chem (2002) 0.85
Pathogenesis of chronic pancreatitis. Gut (1990) 0.85
Sox9: a master regulator of the pancreatic program. Rev Diabet Stud (2014) 0.84
Massive acinar cell apoptosis with secondary necrosis, origin of ducts in atrophic lobules and failure to regenerate in cyanohydroxybutene pancreatopathy in rats. Int J Exp Pathol (1999) 0.83
Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein. Immunology (2006) 0.82
Specific interaction of pancreatic elastase and leucocytes to produce oxygen radicals and its implication in pancreatitis. Gut (1994) 0.81
c-Jun/AP-1 is required for CCK-induced pancreatic acinar cell dedifferentiation and DNA synthesis in vitro. Am J Physiol Gastrointest Liver Physiol (2012) 0.81
A novel model of severe gallstone pancreatitis: murine pancreatic duct ligation results in systemic inflammation and substantial mortality. Pancreatology (2010) 0.80
Phospholipase A2 isoforms in acute pancreatitis. Ann Surg (2001) 0.80
Epithelial progenitor 1, a novel factor associated with epithelial cell growth and differentiation. Endocrine (2010) 0.77
Intra-pancreatic release of bradykinin during the course experimental pancreatitis in rat. Mediators Inflamm (1996) 0.75
Anterior Gradient 2 (AGR2) Induced Epidermal Growth Factor Receptor (EGFR) Signaling Is Essential for Murine Pancreatitis-Associated Tissue Regeneration. PLoS One (2016) 0.75
Selection of AUG initiation codons differs in plants and animals. EMBO J (1987) 12.73
Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol (1995) 4.01
Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology (1998) 3.95
Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Virchows Arch A Pathol Anat Histol (1977) 3.54
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest (1998) 2.90
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology (1993) 2.83
Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. EMBO J (1995) 2.76
Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional study. BMJ (1997) 2.65
p300 acts as a transcriptional coactivator for mammalian Notch-1. Mol Cell Biol (2001) 2.64
Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene (1997) 2.58
Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res (2001) 2.29
NF-kappaB/Rel activation in cerulein pancreatitis. Gastroenterology (1999) 2.21
Evaluating pain and the quality of life in chronic pancreatitis. Int J Pancreatol (1997) 2.16
The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J Virol (1995) 2.07
Condensation-sorting events in the rough endoplasmic reticulum of exocrine pancreatic cells. J Cell Biol (1989) 2.06
A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev (2001) 2.05
[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03
Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy (1999) 2.02
[Prospective Epidemiologic Study of Epigastric Discomfort (PRESTO). Ground work and preliminary results]. Dtsch Med Wochenschr (1999) 2.01
Parental smoking and infection with Helicobacter pylori among preschool children in southern Germany. Epidemiology (1998) 1.98
NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol (1998) 1.96
Helicobacter pylori among preschool children and their parents: evidence of parent-child transmission. J Infect Dis (1999) 1.96
Metabolic and weight-loss effects of a long-term dietary intervention in obese patients. Am J Clin Nutr (1999) 1.92
Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells. Cancer Res (2000) 1.90
Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats. Am J Physiol (1998) 1.89
Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study. Endoscopy (2008) 1.76
Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of serine threonine kinases. J Biol Chem (2000) 1.76
Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology (2001) 1.75
Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70s6K pathway in human pancreatic cancer cells. Cancer Res (1999) 1.67
Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer (1995) 1.67
Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev (1999) 1.64
Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology (1998) 1.60
Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene (1999) 1.60
Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology (2000) 1.56
Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results. Obes Res (2000) 1.56
A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res (2000) 1.55
Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Biochem Biophys Res Commun (1998) 1.52
A pancreatic cancer-specific expression profile. Oncogene (1996) 1.50
Characteristic distribution pattern of Helicobacter pylori in dental plaque and saliva detected with nested PCR. J Med Microbiol (2000) 1.50
Nuclear localization of the human cytomegalovirus tegument protein pp150 (ppUL32). J Gen Virol (1995) 1.47
Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations. Br J Surg (1998) 1.46
Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol Cell Biol (2000) 1.46
Helicobacter pylori and abdominal symptoms: a population-based study among preschool children in southern Germany. Pediatrics (1998) 1.46
Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells. Am J Physiol Cell Physiol (2001) 1.45
Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia. Gut (2004) 1.43
Intracellular localization and expression of the human cytomegalovirus matrix phosphoprotein pp71 (ppUL82): evidence for its translocation into the nucleus. J Gen Virol (1996) 1.43
Hormone-induced pancreatitis. Eur Surg Res (1992) 1.42
Phenylalanine kinetics in healthy volunteers and liver cirrhotics: implications for the phenylalanine breath test. Am J Physiol Endocrinol Metab (2002) 1.41
Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: implications in pathogenesis of pancreas fibrosis. Lab Invest (2000) 1.40
Sympathetic modulation of lipolysis in subcutaneous adipose tissue: effects of gender and energy restriction. J Lab Clin Med (1999) 1.40
Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int J Cancer (2000) 1.39
Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. Cancer Res (2001) 1.36
Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro. Pancreas (1987) 1.32
CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models. Gut (2009) 1.31
Time course and cellular source of pancreatic regeneration following acute pancreatitis in the rat. Pancreas (1986) 1.26
A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut (1999) 1.26
Balance of expression of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in chronic pancreatitis. Z Gastroenterol (1994) 1.25
TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. Int J Cancer (2001) 1.24
Alteration of membrane fusion as a cause of acute pancreatitis in the rat. Dig Dis Sci (1982) 1.24
S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol (2010) 1.20
Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology (2001) 1.20
Dissociation and reassembly of adherens junctions during experimental acute pancreatitis. Gastroenterology (1997) 1.19
Oxidized low-density lipoproteins bind to the scavenger receptor, CD36, of hepatic stellate cells and stimulate extracellular matrix synthesis. Hepatology (2001) 1.19
Human cytomegalovirus late-phase maturation is blocked by stably expressed UL32 antisense mRNA in astrocytoma cells. J Gen Virol (1997) 1.19
Enhancement of transforming growth factor beta 1 expression in the rat pancreas during regeneration from caerulein-induced pancreatitis. Eur J Clin Invest (1994) 1.19
From acinar cell damage to systemic inflammatory response: current concepts in pancreatitis. Pancreatology (2001) 1.18
Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene. Cancer Res (1997) 1.17
NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases. Gastroenterology (2000) 1.17
Human acute pancreatitis: its pathogenesis in the light of immunocytochemical and ultrastructural findings in acinar cells. Virchows Arch A Pathol Anat Histopathol (1986) 1.17
Treatment of pain with pancreatic extracts in chronic pancreatitis: results of a prospective placebo-controlled multicenter trial. Digestion (1992) 1.16
Regulated secretion of mature cathepsin B from rat exocrine pancreatic cells. Eur J Cell Biol (1991) 1.15
TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation. Oncogene (2000) 1.14
[E: [Electron microscopic studies on the action of cobalt chloride on the exocrine pancreatic tissue in guinea pigs]. Virchows Arch B Cell Pathol (1969) 1.14
Experimental animal models of acute pancreatitis. Int J Pancreatol (1994) 1.13
bax, but not bcl-2, influences the prognosis of human pancreatic cancer. Gut (1998) 1.12
Studies on intracellular transport of secretory proteins in the rat exocrine pancreas. II. Inhibition of antimicrotubular agents. Virchows Arch A Pathol Anat Histol (1975) 1.12
Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis. Genes Chromosomes Cancer (1997) 1.12
Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development. Oncogene (2012) 1.11
A direct effect of activated human p53 on nuclear DNA replication. EMBO J (1995) 1.10
Disassembly of rat pancreatic acinar cell cytoskeleton during supramaximal secretagogue stimulation. Am J Physiol (1995) 1.10
Prevalence and determinants of Helicobacter pylori infection in preschool children: a population-based study from Germany. Int J Epidemiol (1998) 1.09
Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. J Hepatol (1998) 1.08
Extracellular matrix is reduced by inhibition of transforming growth factor beta1 in pancreatitis in the rat. Gastroenterology (1997) 1.08
Effects of fibrogenic mediators on the development of pancreatic fibrosis in a TGF-beta1 transgenic mouse model. Am J Physiol Gastrointest Liver Physiol (2001) 1.06
Histochemical and ultrastructural characteristics of tubular complexes in human acute pancreatitis. Dig Dis Sci (1989) 1.06
Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer. Ann Surg (1998) 1.06
Inhibition of human cytomegalovirus maturation by brefeldin A. J Gen Virol (1992) 1.04
Helplessness in the helpers. Br J Med Psychol (1972) 1.04
High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut (2002) 1.04
Helicobacter pylori in dental plaque: a comparison of different PCR primer sets. Dig Dis Sci (1999) 1.04
Aloneness and borderline psychopathology: the possible relevance of child development issues. Int J Psychoanal (1979) 1.04
Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate). Pancreas (1986) 1.03
Effects of the immunosuppressants cyclosporin A and FK 506 on exocytosis in the rat exocrine pancreas in vitro. Br J Pharmacol (1993) 1.02
Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol (1992) 1.02
Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer. Gene (1998) 1.02
Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases. Histopathology (1985) 1.01
Inhibition and facilitation of lacrimal flow by beta-adrenergic drugs. Acta Ophthalmol (Copenh) (1979) 1.01